Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites

NCT04267575 is registered in ClinicalTrials.gov with Jerome Canady, M.D. as lead sponsor.

NCT NCT04267575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04267575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites
Lead sponsor
Jerome Canady, M.D.
Phase
Not applicable
Overall status
Unknown status
Start date
July 30, 2019
Completion date
April 14, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent malignant solid neoplasm, stage iv bladder cancer, stage iv breast cancer, stage iv colon cancer, stage iv colorectal cancer, stage iv fallopian tube cancer, stage iv gastric cancer, stage iv liver cancer, stage iv lung cancer, stage iv non-small cell lung cancer, stage iv ovarian cancer, stage iv pancreatic cancer, stage iv prostate cancer, stage iv rectal cancer, stage iv renal cell cancer, stage iv small intestinal cancer